Literature DB >> 9751519

Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8.

L Rothe1, P Collin-Osdoby, Y Chen, T Sunyer, L Chaudhary, A Tsay, S Goldring, L Avioli, P Osdoby.   

Abstract

Chemokines, including interleukin-8 (IL-8), function as key mediators in diverse inflammatory disorders via promoting the recruitment, proliferation, and activation of vascular and immune cells. IL-8 levels are elevated in inflammatory diseases, such as rheumatoid arthritis, osteoarthritis, osteomyelitis, and periodontal disease, that also exhibit progressive bone loss. Therefore, it is possible that IL-8 contributes to the osteopenia associated with these pathological conditions. Although macrophages, neutrophils, and endothelial cells are considered the primary sources of inflammation-induced IL-8 increases, we report here for the first time that human bone marrow-derived osteoclast-like cells (hOCL) as well as authentic bone-resorbing human osteoclasts (hOC) isolated from osteoporotic femoral heads express messenger RNA (mRNA) for IL-8 and secrete high levels of IL-8 during culture. Basal IL-8 release by cultured hOC or hOCL was orders of magnitude greater than the release of the proinflammatory cytokines IL-1beta, IL-6, and tumor necrosis factor-alpha. At a cellular level, in situ hybridization analysis revealed that IL-8 mRNA was expressed in resorbing hOC of rheumatoid arthritic pannus and was substantially greater than that expressed in hOC of noninflammatory giant cell tumor of bone tissue. Therefore, the potential inflammation-mediated induction of IL-8 was directly assessed using cultured hOCL. IL-8 release was stimulated by proinflammatory signals (IL-1alpha, tumor necrosis factor-alpha, lipopolysaccharide, or phorbol 12-myristate 13-acetate), unaffected by various other osteotropic modulators (transforming growth factor-beta1 and -beta3, IL-6, 17beta-estradiol, or calcitonin) and was decreased by interferon-gamma, vitamin D3, and the antiinflammatory glucocorticoid dexamethasone. Changes in IL-8 secretion were paralleled by corresponding changes in IL-8 mRNA steady state levels. We conclude that hOC and hOCL synthesize and secrete high constitutive and inflammation-stimulated levels of the chemokine IL-8. Consequently, hOC-derived IL-8 could act as an important regulatory signal for bone, vascular, and immune cell recruitment and activation during normal and pathological bone remodeling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751519     DOI: 10.1210/endo.139.10.6247

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

1.  Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases.

Authors:  A S Taha; V Grant; R W Kelly
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

2.  The transcription factor DLX3 regulates the osteogenic differentiation of human dental follicle precursor cells.

Authors:  Sandra Viale-Bouroncle; Oliver Felthaus; Gottfried Schmalz; Gero Brockhoff; Torsten E Reichert; Christian Morsczeck
Journal:  Stem Cells Dev       Date:  2012-02-07       Impact factor: 3.272

3.  Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells.

Authors:  Xiaojia Chen; Jia Lu; Yuhua Ji; An Hong; Qiuling Xie
Journal:  Tumour Biol       Date:  2013-09-12

Review 4.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

5.  Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.

Authors:  Dallas Jones; Laurie H Glimcher; Antonios O Aliprantis
Journal:  J Clin Invest       Date:  2011-07-01       Impact factor: 14.808

Review 6.  Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis.

Authors:  Anca I Catrina; Camilla I Svensson; Vivianne Malmström; Georg Schett; Lars Klareskog
Journal:  Nat Rev Rheumatol       Date:  2016-12-15       Impact factor: 20.543

7.  Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.

Authors:  T Sunyer; J Lewis; P Collin-Osdoby; P Osdoby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

8.  Effect of zoledronate on oral wound healing in rats.

Authors:  Junro Yamashita; Kiyono Koi; Dong-Ye Yang; Laurie K McCauley
Journal:  Clin Cancer Res       Date:  2010-12-13       Impact factor: 12.531

9.  Predictors of osteoclast activity in patients with sickle cell disease.

Authors:  Mehdi Nouraie; Kevin Cheng; Xiaomei Niu; Evadne Moore-King; Margaret F Fadojutimi-Akinsi; Caterina P Minniti; Craig Sable; Sohail Rana; Niti Dham; Andrew Campbell; Gregory Ensing; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

10.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.